NCT06665841Not yet recruiting
Correlation Between Selenium Levels in Human Tissues and HPV-related Cervical Lesions and Outcomes
Source: ClinicalTrials.gov · Last updated 30 Oct 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study investigates the relationship between selenium levels in human tissues and the persistence of HPV (human papillomavirus) infection, particularly focusing on cervical-related lesions. The main objectives are to explore the correlation between selenium levels in different body samples (hair, nails, urine, and blood) and to evaluate selenium's potential protective effects against HPV persistence and its progression to cervical lesions. Key goals of the study include: Determining whether non-invasive monitoring (e.g., hair, nails, urine) can accurately reflect blood selenium levels. Understanding how selenium levels fluctuate in women with persistent HPV infection, and whether selenium supplementation can reduce the risk of HPV-related cervical disease progression. Exploring selenium's role in enhancing immune function, especially in older adults, to help clear HPV infection. By recruiting volunteers for selenium level testing and tracking HPV-positive women over time, this research aims to provide evidence on the effectiveness of selenium in preventing cervical cancer progression and potentially clearing HPV infections.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 200 (estimated)
- First submitted
- 28 Oct 2024
- Start date
- 1 Nov 2024
- Primary completion date
- 30 Jun 2027
- Lead sponsor
- Second Affiliated Hospital of Wenzhou Medical University
- Diseases
- Cervical cancer
- NCT number
- NCT06665841
What you commit to
- Study type: Observational
- Planned participants: 200
- From 1 Nov 2024 to the primary completion date, 30 Jun 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous diagnosis of HPV positivity and those who have received treatment;
Other
- Pregnant individuals;
- Individuals who refuse to cooperate.
Who the study is looking for
- Aged 18 to 65 years;
- No history of sexual activity within the past 3 days;
- No history of cervical surgery;
- No history of using contraceptives, hormone therapy, or exposure to metals;
- No history of cardiovascular, cerebrovascular, liver, kidney, or thyroid diseases;
- All participants must sign a written informed consent form prior to sampling and agree to cooperate with the study.
Age in the registry: 18 years to 65 years · Sex: Female · Accepts healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.